146 related articles for article (PubMed ID: 32612205)
1. Genome-wide investigation of gene-cancer associations for the prediction of novel therapeutic targets in oncology.
Bazaga A; Leggate D; Weisser H
Sci Rep; 2020 Jul; 10(1):10787. PubMed ID: 32612205
[TBL] [Abstract][Full Text] [Related]
2. Machine learning prediction of oncology drug targets based on protein and network properties.
Dezső Z; Ceccarelli M
BMC Bioinformatics; 2020 Mar; 21(1):104. PubMed ID: 32171238
[TBL] [Abstract][Full Text] [Related]
3. Application of network link prediction in drug discovery.
Abbas K; Abbasi A; Dong S; Niu L; Yu L; Chen B; Cai SM; Hasan Q
BMC Bioinformatics; 2021 Apr; 22(1):187. PubMed ID: 33845763
[TBL] [Abstract][Full Text] [Related]
4. In silico prediction of novel therapeutic targets using gene-disease association data.
Ferrero E; Dunham I; Sanseau P
J Transl Med; 2017 Aug; 15(1):182. PubMed ID: 28851378
[TBL] [Abstract][Full Text] [Related]
5. A Machine Learning Approach for Drug-target Interaction Prediction using Wrapper Feature Selection and Class Balancing.
Redkar S; Mondal S; Joseph A; Hareesha KS
Mol Inform; 2020 May; 39(5):e1900062. PubMed ID: 32003548
[TBL] [Abstract][Full Text] [Related]
6. Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology.
Hudson IL
Methods Mol Biol; 2021; 2190():167-184. PubMed ID: 32804365
[TBL] [Abstract][Full Text] [Related]
7. Multi-view self-attention for interpretable drug-target interaction prediction.
Agyemang B; Wu WP; Kpiebaareh MY; Lei Z; Nanor E; Chen L
J Biomed Inform; 2020 Oct; 110():103547. PubMed ID: 32860883
[TBL] [Abstract][Full Text] [Related]
8. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
[TBL] [Abstract][Full Text] [Related]
9. Empowering the discovery of novel target-disease associations via machine learning approaches in the open targets platform.
Han Y; Klinger K; Rajpal DK; Zhu C; Teeple E
BMC Bioinformatics; 2022 Jun; 23(1):232. PubMed ID: 35710324
[TBL] [Abstract][Full Text] [Related]
10. Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network.
Tang Z; Wei G; Zhang L; Xu Z
Mol Med Rep; 2019 Jun; 19(6):4806-4818. PubMed ID: 31059106
[TBL] [Abstract][Full Text] [Related]
11. Integration of machine learning and genome-scale metabolic modeling identifies multi-omics biomarkers for radiation resistance.
Lewis JE; Kemp ML
Nat Commun; 2021 May; 12(1):2700. PubMed ID: 33976213
[TBL] [Abstract][Full Text] [Related]
12. Druggable cancer secretome: neoplasm-associated traits.
Narayanan R
Cancer Genomics Proteomics; 2015; 12(3):119-31. PubMed ID: 25977171
[TBL] [Abstract][Full Text] [Related]
13. Introduction: Cancer Gene Networks.
Clarke R
Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
[TBL] [Abstract][Full Text] [Related]
14. Predicting gene knockout effects from expression data.
Rosenski J; Shifman S; Kaplan T
BMC Med Genomics; 2023 Feb; 16(1):26. PubMed ID: 36803845
[TBL] [Abstract][Full Text] [Related]
15. Essential gene prediction using limited gene essentiality information-An integrative semi-supervised machine learning strategy.
Nandi S; Ganguli P; Sarkar RR
PLoS One; 2020; 15(11):e0242943. PubMed ID: 33253254
[TBL] [Abstract][Full Text] [Related]
16. GuiltyTargets: Prioritization of Novel Therapeutic Targets With Network Representation Learning.
Muslu O; Hoyt CT; Lacerda M; Hofmann-Apitius M; Frohlich H
IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(1):491-500. PubMed ID: 32750869
[TBL] [Abstract][Full Text] [Related]
17. Integrating Biological Networks for Drug Target Prediction and Prioritization.
Ji X; Freudenberg JM; Agarwal P
Methods Mol Biol; 2019; 1903():203-218. PubMed ID: 30547444
[TBL] [Abstract][Full Text] [Related]
18. Predicting potential cancer genes by integrating network properties, sequence features and functional annotations.
Liu W; Xie H
Sci China Life Sci; 2013 Aug; 56(8):751-7. PubMed ID: 23838808
[TBL] [Abstract][Full Text] [Related]
19. Optimisation of cancer classification by machine learning generates an enriched list of candidate drug targets and biomarkers.
Ramroach S; Joshi A; John M
Mol Omics; 2020 Apr; 16(2):113-125. PubMed ID: 32095794
[TBL] [Abstract][Full Text] [Related]
20. Predicting protein targets for drug-like compounds using transcriptomics.
Pabon NA; Xia Y; Estabrooks SK; Ye Z; Herbrand AK; Süß E; Biondi RM; Assimon VA; Gestwicki JE; Brodsky JL; Camacho CJ; Bar-Joseph Z
PLoS Comput Biol; 2018 Dec; 14(12):e1006651. PubMed ID: 30532261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
